Brief: Sangamo Therapeutics To Transition Common Stock To Otcqb Venture Market On May 5, 2026
29/04/2026 13:09
April 29 (Reuters) - Sangamo Therapeutics Inc SGMO.O: SANGAMO THERAPEUTICS INC - TO TRANSITION COMMON STOCK TO OTCQB VENTURE MARKET ON MAY 5, 2026 Source text: ID:nGNX6CrZjH Further company coverage: SGMO.O ((Reuters.Briefs@thomsonreuters.com;))